Kymera CEO on fast-tracked eczema oral treatment trial

CNBC’s “Fast Money” team is joined by Nello Mainolfi, founder, president and CEO of Kymera Therapeutics, to discuss the company's recent performance, its oral treatment trials for eczema drug and more.